A Study to Evaluate the Efficacy and Safety of AMG 714 in Adult Patients With Celiac Disease

NCT02637141 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Celiac Disease

Interventions

BIOLOGICAL: AMG 714
BIOLOGICAL: Placebo
OTHER: Placebo Gluten Challenge
OTHER: Gluten Challenge

Sponsor

Amgen